Home Craig Hallum Reiterates Buy Rating for Ligand Pharmaceuticals
 

Keywords :   


Craig Hallum Reiterates Buy Rating for Ligand Pharmaceuticals

2015-05-24 10:58:48| Biotech - Topix.net

's stock had its "buy" rating restated by investment analysts at Craig Hallum in a note issued to investors on Saturday. They currently have a $105.00 target price on the biotechnology company's stock, up from their previous target price of $90.00.

Tags: buy rating craig pharmaceuticals

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
27.113Q3
27.113DS 52
27.11
27.11Xotic Effects BB+ Plus
27.11
27.11 J. Lindeberg SS /
27.11
27.11DX
More »